a-TGF (34-43), rat

a-TGF (34-43), rat

GHRF

pTH (1-34) (rat)

31-acetamido-7-[3-(diaminomethylideneamino)propyl]-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-5-ylmethyl)-6,9,12,15,18,21,24,27,30-nonaoxo-10,16-di(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carboxamid

6-((2-(1-oxidaneyl)-13,24,33,44,53,63-hexaoxin-4-yl)oxy)-13,23,34,43,53,64-hexaoxin-3-ol

2β,3β-Dihydroxy-1β-methyl-8-methylenegibbane-1α,4aα,10β-tricarboxylic acid

1-(isopropylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

O-Octyl Dabigatran Ethyl Ester

Tert-butyl 3-((tert-butyldimethylsilyl)oxy)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)azetidine-1-carboxylate

5-methoxy-2,3-dihydro-1H-isoindole-2-carboxamide

2-(1H-indol-4-yl)propanal

1-Amino-5-(morpholin-4-yl)pentan-3-one

2-Fluoro-N-hydroxy-4-methylbenzimidoyl Chloride

Methyl 4-[1-(hydroxymethyl)cyclopropyl]benzoate

4-Amino-2,2-dimethylpentane-1,5-diol

2-[4-(4-aminophenyl)-1H-pyrazolo[3,4-c]pyridin-1-yl]ethan-1-ol